Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen
Cancer stem cells (CSCs) can act as the cellular drivers of tumors harnessing stem cell properties that contribute to tumorigenesis either as founder elements or by the gain of stem cell traits by the malignant cells. Thus, CSCs can self-renew and generate the cellular heterogeneity of tumors includ...
Saved in:
Main Authors: | Richard Harrop (Author), Eric O'Neill (Author), Peter L. Stern (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
by: Tian-Yu Zhu, et al.
Published: (2023) -
Correction: Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
by: Tian-Yu Zhu, et al.
Published: (2023) -
Shifting perspectives from "oncogenic" to oncofetal proteins; how these factors drive placental development
by: Rachel C. West, et al.
Published: (2018) -
Placenta-Specific Protein 1: A Potential Key to Many Oncofetal-Placental OB/GYN Research Questions
by: Eric J. Devor, et al.
Published: (2014) -
Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
by: Javad Masoumi, et al.
Published: (2021)